Literature DB >> 33139307

Clinical course of COVID-19 in a cohort of 342 familial Mediterranean fever patients with a long-term treatment by colchicine in a French endemic area.

Rim Bourguiba1, Marion Delplanque1, Caroline Vinit2, Felix Ackermann3, Léa Savey1, Gilles Grateau1, Veronique Hentgen2, Sophie Georgin-Lavialle4.   

Abstract

Entities:  

Keywords:  amyloidosis; familial Mediterranean fever; inflammation

Mesh：

Substances：

Year:  2020        PMID： 33139307     DOI： 10.1136/annrheumdis-2020-218707

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  16 in total

1.  A Response to: Letter to the Editor Regarding the Article: "Colchicine Against SARS-CoV-2 Infection: What is the Evidence?"

Authors:  Alexandros A Drosos; Eleftherios Pelechas; Vassiliki Drossou; Paraskevi V Voulgari
Journal:  Rheumatol Ther       Date:  2022-05-27

2.  COVID-19 and autoinflammatory diseases: prevalence and outcomes of infection and early experience of vaccination in patients on biologics.

Authors:  Claire J Peet; Charalampia Papadopoulou; Bella Ruth M Sombrito; Michael R Wood; Helen J Lachmann
Journal:  Rheumatol Adv Pract       Date:  2021-08-23

3.  Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine.

Authors:  Mert Oztas; Murat Bektas; Ilker Karacan; Numune Aliyeva; Ayten Dag; Sarvan Aghamuradov; Selim Berke Cevirgen; Selma Sari; Murat Bolayirli; Gunay Can; Gulen Hatemi; Emire Seyahi; Huri Ozdogan; Ahmet Gul; Serdal Ugurlu
Journal:  J Med Virol       Date:  2022-03-29       Impact factor: 20.693

4.  COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI - the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseases.

Authors:  Rim Bourguiba; Maeva Kyheng; Isabelle Koné-Paut; Diane Rouzaud; Jerome Avouac; Mathilde Devaux; Nassim Ait Abdallah; Bruno Fautrel; Nicole Ferreira-Maldent; Vincent Langlois; Emmanuel Ledoult; Hubert Nielly; Viviane Queyrel; Jérémie Sellam; Nathalie Tieulie; Pascal Chazerain; Philippe Evon; Julien Labreuche; Léa Savey; Veronique Hentgen; Gilles Grateau; Sophie Georgin-Lavialle
Journal:  RMD Open       Date:  2022-05

5.  Influence of colchicine prescription in COVID-19-related hospital admissions: a survival analysis.

Authors:  Alfredo Madrid-García; Inés Pérez; José Ignacio Colomer; Leticia León-Mateos; Juan A Jover; Benjamín Fernández-Gutiérrez; Lydia Abásolo-Alcazar; Luis Rodríguez-Rodríguez
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-03-26       Impact factor: 5.346

6.  The impact of COVID-19 on familial Mediterranean fever: a nationwide study.

Authors:  Zafer Günendi; Fatma Gül Yurdakul; Hatice Bodur; Ahmet Kıvanç Cengiz; Ülkü Uçar; Hasan Fatih Çay; Nesrin Şen; Yaşar Keskin; Gülcan Gürer; Meltem Alkan Melikoğlu; Duygu Altıntaş; Hülya Deveci; Merve Baykul; Kemal Nas; Remzi Çevik; Ali Yavuz Karahan; Murat Toprak; Sertaç Ketenci; Mehmet Nayimoğlu; İlhan Sezer; Ali Nail Demir; Hilal Ecesoy; Mehmet Tuncay Duruöz; Ozan Volkan Yurdakul; Ayşe Banu Sarıfakıoğlu; Şebnem Ataman
Journal:  Rheumatol Int       Date:  2021-05-25       Impact factor: 2.631

7.  The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet's syndrome.

Authors:  Guzin Ozcifci; Tahacan Aydin; Zeynep Atli; Ilker Inanc Balkan; Fehmi Tabak; Mert Oztas; Yesim Ozguler; Serdal Ugurlu; Gulen Hatemi; Melike Melikoglu; Izzet Fresko; Vedat Hamuryudan; Emire Seyahi
Journal:  Rheumatol Int       Date:  2021-11-25       Impact factor: 3.580

Review 8.  Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine.

Authors:  Dimitrios A Vrachatis; Konstantinos A Papathanasiou; Sotiria G Giotaki; Konstantinos Raisakis; Charalampos Kossyvakis; Andreas Kaoukis; Fotis Kolokathis; Gerasimos Deftereos; Konstantinos E Iliodromitis; Dimitrios Avramides; Harilaos Bogossian; Gerasimos Siasos; George Giannopoulos; Bernhard Reimers; Alexandra Lansky; Jean-Claude Tardif; Spyridon Deftereos
Journal:  J Clin Med       Date:  2021-10-31       Impact factor: 4.241

9.  COVID-19 outcomes in patients with familial Mediterranean fever: a retrospective cohort study.

Authors:  Serdar Can Güven; Abdulsamet Erden; Özlem Karakaş; Berkan Armağan; Eren Usul; Ahmet Omma; Orhan Küçükşahin
Journal:  Rheumatol Int       Date:  2021-02-21       Impact factor: 2.631

Review 10.  COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review.

Authors:  Kemal Nas; Nuran Eryilmaz; Mehmet Faruk Geyik; Ayfer Altaş
Journal:  Rheumatol Int       Date:  2021-02-21       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.